66910 Federal Register / Vol. 66, No. 248 / Thursday, December 27, 2001 / Notices

1 Individuals with the following statuses are

eligible for ORR-funded benefits (see 45 CFR 400.43

and ORR State Letters 00–17 and 01–13): (1)

Refugees under § 207 of the Immigration and

Nationality Act (INA), (2) asylees whose status was

granted under § 208 of the INA, (3) Cuban and

Haitian entrants, in accordance with the

requirements in 45 CFR part 401, (4) certain

Amerasians from Vietnam and (5) victims of severe

forms of trafficking.

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Agency Recordkeeping/Reporting

Requirements Under Emergency

Review by the Office of Management

and Budget (OMB)

Title: Confirmation of Immigration

Status for Recently-Released Indefinite

Detainees.

OMB No.: New request.

Description: On June 28, 2001, the

U.S. Supreme Court issued its decision

in Zadvydas v. Davis. The case

concerned ‘‘indefinite detainees’’ or

‘‘lifers,’’ which are terms used to refer

to noncitizens who, after having served

time for a criminal conviction and being

given a final order of removal by the

Immigration and Naturalization Service

(INS), remain indefinitely in U.S. jails

because their home country and no

other countries will accept them. In

Zadvydas the Supreme Court held that

the law limits an ‘‘alien’s detention to

a period reasonably necessary to bring

about that alien’s removal from the

United States, and does not permit

indefinite detention.’’ Shortly after the

Supreme Court decision, Attorney

General John Ashcroft ordered the INS

to begin looking into the release of

certain indefinite detainees. Some of

these individuals already have been

release from detention.

In a number of cases, indefinite

detainees originally came to the U.S. as

refugees or had another status that made

them eligible for Office of Refugee

Resettlement (ORR)-funded benefits and

services.1 These individuals, upon

release from detention, may come to

benefit-granting agencies for assistance.

Prior to providing benefits or services,

benefit-granting agencies must

determine status, identity, the date an

individual initially became eligible for

benefits (i.e., entry date) and, in certain

cases, nationality. However, benefitgranting agencies are unable to make

these determinations for recently

released detainees for a number of

reasons including lack of INS

documentation showing status and

entry date and incomplete and untimely

responses from the INS Systematic

Alien Verification for Entitlements

(SAVE) System.

In this notice, ACF announces that

ORR has worked out an agreement with

the INS under which benefit-granting

agencies will contact ORR and provide

as much of the following information as

possible for a recently released detainee

wishing to access benefits: name, alien

registration number, date of birth, social

security number, home country, number

on the I–94 card, parents’ names,

driver’s license number and copies of

any immigration documents. ORR then

will relay this information to the INS.

INS will tell ORR the individual’s

original immigration status, such as

refugee, and ORR will inform the

benefit-granting agency whether or not

the individual is eligible for assistance.

Respondents: Individuals, State and

local governments, not-for-profit

organizations.

Annual Burden Estimates

Number of Respondents: 10.

Number of Responses per

Respondent: 10.

Average Burden Hours per Response:

0.25.

Estimated Total Annual Burden

Hours: 25 hours.

Additional Information: ACF is

requesting that OMB grant a 180 day

approval for this information collection

under procedures for emergency

processing by December 21, 2001. A

copy of this information collection, with

applicable supporting documentation,

may be obtained by calling the

Administration for Children and

Families, Reports Clearance Officer,

Robert Sargis at (202) 690–7275. In

addition, a request may be made by

sending an e-mail request to:

rsargis@acf.dhhs.gov.

Comments and questions about the

information collection described above

should be directed to the following

address by December 21, 2001: Office of

Information and Regulatory Affairs,

Attn: OMB Desk Officer for ACF, Office

of Management and Budget, Paper

Reduction Project, 725 17th Street, NW.,

Washington, DC 20503.

Dated: December 18, 2001.

Bob Sargis,

Reports Clearance Officer.

[FR Doc. 01–31676 Filed 12–26–01; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 93D–0398]

Assessment of the Effects of

Antimicrobial Drug Residues From

Food of Animal Origin on the Human

Intestinal Flora; Availability

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

availability for comment of draft

guidance for industry entitled

‘‘Assessment of the Effects of

Antimicrobial Drug Residues from Food

of Animal Origin on the Human

Intestinal Flora.’’ This draft guidance is

a revision of the guidance document no.

52 entitled ‘‘Microbiological Testing of

Antimicrobial Drug Residues in Food,’’

which was implemented in 1996. In this

draft guidance, the agency recommends

a pathway approach for assessing the

microbiological safety of antimicrobial

drug residues in food, rather than the

approach described in the 1996 version

of the guidance. The agency’s decision

to revise this guidance is based on new

information available to the agency.

DATES: You may submit written or

electronic comments at any time.

However, the agency would like to use

these comments during the next meeting

of the International Cooperation on

Harmonisation of Technical

Requirements for Registration of

Veterinary Medicinal Products (VICH)

Microbial Safety Task Force meeting.

You should submit comments

concerning this draft guidance by March

27, 2002 to ensure the incorporation of

your comments at that meeting.

Submit written or electronic

comments on the collection of

information by February 25, 2002.

ADDRESSES: Submit written comments

on the draft guidance to the Dockets

Management Branch (HFA–305), Food

and Drug Administration, 5630 Fishers

Lane, rm. 1061, Rockville, MD 20852.

Submit electronic comments to http://

www.fda.gov/dockets/ecomments. All

comments should be identified with the

full title of the draft guidance and the

docket number found in brackets in the

heading of this document.

Submit written requests for single

copies of the draft guidance to the

Communications Staff (HFV–12), Center

for Veterinary Medicine, Food and Drug

Administration, 7500 Standish Place,

Rockville, MD 20855. Send one selfVerDate 11<MAY>2000 20:11 Dec 26, 2001 Jkt 197001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\27DEN1.SGM pfrm07 PsN: 27DEN1